Maple Rock Capital Partners Inc. Bausch Health Companies Inc. Transaction History
Maple Rock Capital Partners Inc.
- $1.91 Billion
- Q2 2025
A detailed history of Maple Rock Capital Partners Inc. transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Maple Rock Capital Partners Inc. holds 7,808,487 shares of BHC stock, worth $54.7 Million. This represents 2.73% of its overall portfolio holdings.
Number of Shares
7,808,487
Previous 6,797,500
14.87%
Holding current value
$54.7 Million
Previous $44 Million
18.25%
% of portfolio
2.73%
Previous 1.69%
Shares
4 transactions
Others Institutions Holding BHC
# of Institutions
255Shares Held
259MCall Options Held
2.55MPut Options Held
8.57M-
Nomura Holdings Inc Tokyo, M037.2MShares$261 Million0.43% of portfolio
-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$243 Million2.99% of portfolio
-
Goldentree Asset Management LP New York, NY34.3MShares$240 Million23.91% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny32.8MShares$230 Million11.35% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$91 Million0.18% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.53B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...